Search

Your search keyword '"Medical equipment and supplies industry -- Reports"' showing total 2,994 results

Search Constraints

Start Over You searched for: Descriptor "Medical equipment and supplies industry -- Reports" Remove constraint Descriptor: "Medical equipment and supplies industry -- Reports" Topic health Remove constraint Topic: health
2,994 results on '"Medical equipment and supplies industry -- Reports"'

Search Results

1. Researcher at Boston Scientific Corporation Zeroes in on Stroke (Long-Term Clinical Outcomes Following the WATCHMAN Device Use in Medicare Beneficiaries)

2. Medical Physics Unit Researchers Publish Findings in Applied Sciences (Patient-Specific Dosimetry Evaluations in Theranostics Software for Internal Radiotherapy)

3. Data on Biomarkers Described by Researchers at Medtronic (Cardiac sensing at a spinal cord stimulation lead: a promising on-device potential biomarker for pain and wellbeing)

4. Anika Therapeutics, Inc. Files SEC Form 8-K, Current Report: (Jul. 11, 2024)

5. Anika Therapeutics, Inc. Files SEC Form 8-K, Current Report: (May 28, 2024)

6. Anika Therapeutics, Inc. Files SEC Form 8-K, Current Report: (May 8, 2024)

7. Anika Therapeutics, Inc. Files SEC Form 8-K, Current Report: (Mar. 13, 2024)

8. Anika Therapeutics, Inc. Files SEC Form 8-K, Current Report: (Feb. 26, 2024)

9. AtriCure Releases 2023 ESG Report

10. Boston Scientific Corp. Files SEC Form 8-K, Current Report: (Oct. 23, 2024)

11. Resmed Inc. Files SEC Form 144/A, Report of Proposed Sale of Securities: (Oct. 11, 2024)

12. Resmed Inc. Files SEC Form 144, Report of Proposed Sale of Securities: (Oct. 11, 2024)

13. Owens & Minor Inc. Files SEC Form 8-K, Current Report: (Oct. 15, 2024)

14. Steris Plc Files SEC Form 8-K, Current Report: (Oct. 7, 2024)

15. Resmed Inc. Files SEC Form 144, Report of Proposed Sale of Securities: (Oct. 8, 2024)

16. Resmed Inc. Files SEC Form 144, Report of Proposed Sale of Securities: (Oct. 7, 2024)

17. Iridex Corp. Files SEC Form 8-K, Current Report: (Oct. 3, 2024)

18. Conmed Corp. Files SEC Form 8-K, Current Report: (Oct. 4, 2024)

19. Boston Scientific Corp. Files SEC Form 144, Report of Proposed Sale of Securities: (Oct. 7, 2024)

20. Baxter International Inc. Files SEC Form 8-K, Current Report: (Oct. 9, 2024)

21. Angiodynamics Inc. Files SEC Form 8-K, Current Report: (Oct. 3, 2024)

22. Skinvisible, Inc. Files SEC Form 8-K, Current Report: (Oct. 3, 2024)

23. Non Invasive Monitoring Systems Inc. Files SEC Form 8-K, Current Report: (Sept. 27, 2024)

24. Milestone Scientific Inc. Files SEC Form 8-K, Current Report: (Sept. 27, 2024)

25. Icu Medical Inc. Files SEC Form 8-K, Current Report: (Oct. 2, 2024)

26. Icu Medical Inc. Files SEC Form 144, Report of Proposed Sale of Securities: (Oct. 1, 2024)

27. Fonar Corp. Files SEC Form 8-K, Current Report: (Sept. 30, 2024)

28. Conmed Corp. Files SEC Form 8-K, Current Report: (Sept. 30, 2024)

29. Cytosorbents Corp. Files SEC Form 8-K, Current Report: (Oct. 1, 2024)

30. Boston Scientific Corp. Files SEC Form 144, Report of Proposed Sale of Securities: (Oct. 1, 2024)

31. Becton Dickinson & Co Files SEC Form 8-K, Current Report: (Oct. 2, 2024)

32. Baxter International Inc. Files SEC Form 8-K, Current Report: (Sept. 30, 2024)

33. Resmed Inc. Files SEC Form 144, Report of Proposed Sale of Securities: (Sept. 12, 2024)

34. Intuitive Surgical Inc. Files SEC Form 144, Report of Proposed Sale of Securities: (Sept. 12, 2024)

35. Intuitive Surgical Inc. Files SEC Form 144, Report of Proposed Sale of Securities: (Sept. 13, 2024)

36. Haemonetics Corp. Files SEC Form 8-K, Current Report: (Sept. 16, 2024)

37. Stryker Corp. Files SEC Form 144, Report of Proposed Sale of Securities: (Sept. 17, 2024)

38. Stryker Corp. Files SEC Form 144, Report of Proposed Sale of Securities: (Sept. 13, 2024)

39. Patterson Companies, Inc. Files SEC Form 8-K, Current Report: (Sept. 18, 2024)

40. Owens & Minor Inc. Files SEC Form 8-K, Current Report: (Sept. 16, 2024)

41. Hologic Inc. Files SEC Form 8-K, Current Report: (Sept. 13, 2024)

42. Dexcom Inc. Files SEC Form 144, Report of Proposed Sale of Securities: (Sept. 16, 2024)

43. Biolife Solutions Inc. Files SEC Form 144, Report of Proposed Sale of Securities: (Sept. 18, 2024)

44. Baxter International Inc. Files SEC Form 144, Report of Proposed Sale of Securities: (Sept. 16, 2024)

45. Baxter International Inc. Files SEC Form 144, Report of Proposed Sale of Securities: (Sept. 13, 2024)

46. Becton Dickinson & Co Files SEC Form 144, Report of Proposed Sale of Securities: (Sept. 16, 2024)

47. Anika Therapeutics, Inc. Files SEC Form 8-K, Current Report: (Nov. 2, 2023)

48. Anika Therapeutics, Inc. Files SEC Form 8-K, Current Report: (Sept. 21, 2023)

49. Researchers at Hiroshima University Have Reported New Data on Life Sciences (Selective Activation of Ppar Alpha Maintains Thermogenic Capacity of Beige Adipocytes)

50. Predictive Oncology Inc. Files SEC Form 8-K, Current Report: (Jul. 29, 2024)

Catalog

Books, media, physical & digital resources